Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum
- 1 December 2003
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 353 (1) , 57-60
- https://doi.org/10.1016/j.neulet.2003.09.018
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Treatment of amyotrophic lateral sclerosis— What is the next step?Zeitschrift für Neurologie, 2000
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- S-100β protein is upregulated in astrocytes and motor neurons in the spinal cord of patients with amyotrophic lateral sclerosisNeuroscience Letters, 1999
- Creatine kinase values in amyotrophic lateral sclerosisJournal of the Neurological Sciences, 1998
- Decrease of S100 beta protein in serum of patients with amyotrophic lateral sclerosisNeuroscience Letters, 1998
- S100β Induces Neuronal Cell Death Through Nitric Oxide Release from AstrocytesJournal of Neurochemistry, 1997
- Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosisJournal of Neuroscience Research, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- S100 is present in developing chicken neurons and schwann cell and promotes motor neuron survival in vivoJournal of Neurobiology, 1992
- A double‐blind, placebo‐controlled trial of TRH in amyotrophic lateral sclerosisNeurology, 1986